{"id":"W3166150115","doi":"10.1200/jco.2021.39.15_suppl.8038","title":"Once weekly selinexor, carfilzomib, and dexamethasone (XKd) in carfilzomib nonrefractory multiple myeloma (MM) patients.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Hôpital Maisonneuve-Rosemont; Princess Margaret Cancer Centre; University of Calgary; Dalhousie University; Institute of Cancer Research; Queen Elizabeth II Health Sciences Centre; Vancouver General Hospital; CancerCare Manitoba","funders":"Karyopharm Therapeutics","keywords":"Carfilzomib; Medicine; Regimen; Dexamethasone; Bortezomib; Pharmacology; Internal medicine; Refractory (planetary science); Oncology; Multiple myeloma; Cancer research; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006399064,0.000449405,0.0007205221,0.0002565156,0.0002407326,0.0003769615,0.0003426973,0.0004524892,0.001688964],"category_scores_gemma":[0.0003824578,0.0002094677,0.0004944053,0.0002685187,0.0003279255,0.0003836649,0.0002612434,0.0008541921,0.0002939602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006638966,"about_ca_system_score_gemma":0.0006446191,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009621699,"about_ca_topic_score_gemma":0.003382285,"domain_scores_codex":[0.9997646,0.0000908232,0.00001716127,0.00005096139,0.0000255258,0.00005094448],"domain_scores_gemma":[0.9997928,0.00003578461,0.00004104439,0.00001193252,0.000008362055,0.000110259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4598294,0.02689287,0.08399883,0.0007756684,0.0009319118,0.000904222,0.0005299727,0.003452399,0.06800057,0.0003804179,0.002750307,0.3515534],"study_design_scores_gemma":[0.1313167,0.6431501,0.1986759,0.00009404711,0.0008261131,0.001627812,0.0001925772,0.00255295,0.01052001,0.000299237,0.01070968,0.00003488878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966667,0.001858344,0.0001174591,0.0002069767,0.00002569924,0.0002435,0.0001702884,0.00002134834,0.0006896505],"genre_scores_gemma":[0.9979843,0.000625925,0.000338958,0.0001571976,0.00002914251,0.0001379835,0.0002928782,0.000002446284,0.0004311861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001688964,"threshold_uncertainty_score":0.005650103,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1327455390325591,"score_gpt":0.4615143807599671,"score_spread":0.3287688417274079,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}